2018 American Transplant Congress
Taking Your Center's Temperature: Using a Heat Map to Target Your Transplant-Specific Education for Regulatory Compliance
Medical University of South Carolina, Charleston.
Background: Large, multi-organ transplant centers struggle with implementation of a comprehensive strategy for development and execution of a Transplant-specific education plan. Regulatory requirements for staff…2018 American Transplant Congress
Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era
While there is no Medicare time limit for dialysis patients, kidney transplant recipients lose their Medicare coverage 36 months after they receive their transplant. The…2018 American Transplant Congress
Medicare Part D Plans Deny Coverage for Off-Label and Off-Compendia Immunosuppressant Use: A Case Series
Immunosuppressants are a protected drug class under the Medicare Part D benefit, meaning that all drugs in this class must be present on all plan…2017 American Transplant Congress
Transplant Economics Post Implementation of the Affordable Care Act and the Budget Control Act Sequestration Adjustment on Medicare Reimbursement.
1VUMC, Nashville; 2Tx Mgmt Group, San Diego; 3Mayo Clinic, Jacksonville
Purpose: Adjustments in the Affordable Care Act (ACA) of 2010 and sequestration from the Budget Control Act (BCA) of 2011 have impacted Medicare reimbursement for…2017 American Transplant Congress
A Kidney Paired Donation Standard Acquisition Charge.
Introduction: A non-profit kidney paired donation (KPD) organization undertook an Agency for Healthcare Research and Quality (AHRQ)-funded demonstration project to redesign reimbursement for the costs…2017 American Transplant Congress
Twenty Year Trends in Outcomes and Costs Following Kidney Transplantation.
Purpose. Short term outcomes of kidney transplantation (KTx) are excellent, but it is unclear that long term outcomes have improved, despite advances in immunosuppression (IS).…2017 American Transplant Congress
Immunosuppressant Costs for Medicare Part D and Kidney Transplant Recipients Since the Introduction of Generic Formulations in an Incident Kidney Transplant Population.
Background: Substitution of generics (GEN) for brand name (BN) immunosuppressants (IS) has increased in kidney transplant recipients (KTR) since the introduction of GEN mycophenolate mofetil…2017 American Transplant Congress
Initial Experince with Total Pancreatectomy-Islet Auto-Transplantation (TP-IAT) for Chronic Pancreatitis at the University of Louisville.
Chronic pancreatitis (CP) represents a highly significant healthcare challenge in Kentucky. To address this need, we created a TP-IAT program to cure patients of this…2017 American Transplant Congress
The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.
Medicare coverage for kidney transplant recipients aged <65 years in the US ends 3 years posttransplant, but a significant proportion of recipients remain on Medicare…2016 American Transplant Congress
Big Data Predictive Solution to Optimize Kidney Transplant Outcome and Resource Utilization.
Objective: Transplant (Tx) programs often use data in reaction to regulation vs. optimizing outcomes through data driven clinical care. Tx specific issues can detract from…
American Transplant Congress abstracts